Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid CancerMaria E. Cabanillas, Sarah Hamidi, Renata Ferrarotto et al.|Thyroid|2025Cited by 8
Cobimetinib plus atezolizumab for <i>RAS</i> and <i>NF</i>1/2-mutated poorly differentiated thyroid carcinoma.Sarah Hamidi, Brian McKinley, Dzifa Y. Duose et al.|Journal of Clinical Oncology|2024Cited by 4